Search

Your search keyword '"Ponzoni, Maurilio"' showing total 2,041 results

Search Constraints

Start Over You searched for: Author "Ponzoni, Maurilio" Remove constraint Author: "Ponzoni, Maurilio"
2,041 results on '"Ponzoni, Maurilio"'

Search Results

2. Liquid biopsy of cerebrospinal fluid enabling the detection and therapeutic targeting of the BRAFV600E mutation in a patient with overlapping Erdheim-Chester/Rosai-Dorfman disease

4. ZEB1 shapes AML immunological niches, suppressing CD8 T cell activity while fostering Th17 cell expansion

6. A refined cell-of-origin classifier with targeted NGS and artificial intelligence shows robust predictive value in DLBCL

7. Long-term efficacy, safety and neurotolerability of MATRix regimen followed by autologous transplant in primary CNS lymphoma: 7-year results of the IELSG32 randomized trial

9. Genetic and phenotypic attributes of splenic marginal zone lymphoma

10. Germinal Center Dark Zone harbors ATR-dependent determinants of T-cell exclusion that are also identified in aggressive lymphoma

11. Case report: Cytopenias in VEXAS syndrome - a WHO 2022 based approach in a single-center cohort

13. Molecular diagnosis of primary CNS lymphoma in 2024 using MYD88Leu265Proand IL-10

14. A Spatially Resolved Dark- versus Light-Zone Microenvironment Signature Subdivides Germinal Center-Related Aggressive B Cell Lymphomas

15. Primary central nervous system lymphomas: EHA–ESMO Clinical Practice Guideline for diagnosis, treatment and follow‐up.

16. Determining clinical course of diffuse large B-cell lymphoma using targeted transcriptome and machine learning algorithms

18. Improving the antitumor activity of R-CHOP with NGR-hTNF in primary CNS lymphoma: final results of a phase 2 trial

22. Large B-cell lymphoma with IRF4 rearrangement: a multi-centric study with focus on potential misleading phenotypes

25. Oncogene-induced senescence in hematopoietic progenitors features myeloid restricted hematopoiesis, chronic inflammation and histiocytosis

30. R-CHOP preceded by blood-brain barrier permeabilization with engineered tumor necrosis factor-α in primary CNS lymphoma

31. PD-1/PD-L1 expression and interaction by automated quantitative immunofluorescent analysis show adverse prognostic impact in patients with diffuse large B-cell lymphoma having T-cell infiltration: a study from the International DLBCL Consortium Program

32. CAR T cell manufacturing from naive/stem memory T lymphocytes enhances antitumor responses while curtailing cytokine release syndrome

35. Liquid biopsy of cerebrospinal fluid enabling the detection and therapeutic targeting of the BRAFV600E mutation in a patient with overlapping Erdheim-Chester/Rosai-Dorfman disease.

36. Primary central nervous system marginal zone lymphoma.

37. Tumor-infiltrating normal B cells revealed by immunoglobulin repertoire clonotype analysis are highly prognostic and crucial for antitumor immune responses in DLBCL

38. Liquid biopsy of cerebrospinal fluid enabling the detection and therapeutic targeting of the BRAFV600E mutation in a patient with overlapping Erdheim-Chester/Rosai-Dorfman disease

39. ETS1 phosphorylation at threonine 38 is associated with the cell of origin of diffuse large B cell lymphoma and sustains the growth of tumour cells

40. ZEB1 shapes AML immunological niches suppressing CD8 T-cell activity while fostering Th17 cell expansion

41. Clinical Significance of PTEN Deletion, Mutation, and Loss of PTEN Expression in De Novo Diffuse Large B-Cell Lymphoma

42. BET bromodomain inhibitor birabresib in mantle cell lymphoma: in vivo activity and identification of novel combinations to overcome adaptive resistance

43. Spontaneous remission of choroidal involvement by chronic myelomonocytic leukemia: a case report.

44. HMGA1-pseudogene7 transgenic mice develop B cell lymphomas

45. XPO1 expression worsens the prognosis of unfavorable DLBCL that can be effectively targeted by selinexor in the absence of mutant p53

46. Whole-brain radiotherapy or autologous stem-cell transplantation as consolidation strategies after high-dose methotrexate-based chemoimmunotherapy in patients with primary CNS lymphoma: results of the second randomisation of the International Extranodal Lymphoma Study Group-32 phase 2 trial

48. Data from IL1R8 Deficiency Drives Autoimmunity-Associated Lymphoma Development

49. Supplementary Tables from IL1R8 Deficiency Drives Autoimmunity-Associated Lymphoma Development

50. Supplementary Tables from Immune Profiling and Quantitative Analysis Decipher the Clinical Role of Immune-Checkpoint Expression in the Tumor Immune Microenvironment of DLBCL

Catalog

Books, media, physical & digital resources